Multitargeted biological actions of polydatin in preventing pseudogout acute attack

Chiara Baggio1, Paola Galozzi2, Amelia Damasco1

  • 1Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.

Abstract

Insights

Polydatin (PD) prevents inflammatory responses to calcium pyrophosphate (CPP) crystals in mice, protecting joints and muscles. Its anti-inflammatory effects involve regulating leukocyte migration and reducing pro-inflammatory mediators via SIRT1 activation.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Polydatin (PD) has demonstrated protective effects against calcium pyrophosphate (CPP) crystal-induced arthritis in previous studies.
  • Understanding the underlying mechanisms of PD's anti-inflammatory action is crucial for its therapeutic development.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which polydatin (PD) exerts its anti-inflammatory effects against calcium pyrophosphate (CPP) crystal-induced arthritis.
  • To investigate the role of SIRT1 and leukocyte migration pathways in PD's therapeutic action.

Main Methods:

  • Acute arthritis was induced in mice via CPP crystal injection; animals received prophylactic treatment with PD or colchicine.
  • Histological analysis, muscle strength testing, protein arrays, and in vitro assays (monocyte stimulation, chemotaxis) were employed.
  • Specific inhibitors and ELISA were used to assess inflammatory mediators, leukocyte migration, and SIRT1 involvement.

Main Results:

  • PD treatment significantly reduced ankle swelling and inflammatory damage in joints and gastrocnemius muscles caused by CPP crystals.
  • PD modulated inflammatory pathways, including leukocyte migration and angiogenesis, and reduced pro-inflammatory cytokines and VEGF in vitro.
  • PD's anti-inflammatory effects were linked to SIRT1 activation and inhibition of CCR-1, which reduced monocyte activation and PBMCs migration.

Conclusions:

  • Polydatin (PD) effectively prevents inflammatory responses to CPP crystals in mice, preserving articular and muscular integrity.
  • The anti-inflammatory properties of PD are mediated by regulating leukocyte migration and suppressing pro-inflammatory mediators, with a key role for SIRT1 activation.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
599
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
153
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
446
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.5K